Literature DB >> 190584

Protective efficacy of vaccination in children in four episodes of natural varicella and zoster in the ward.

Y Asano, H Nakayama, T Yazaki, S Ito, S Isomura.   

Abstract

It was previously reported that a live varicella vaccine (Oka strain) has been developed and that the immediate vaccination of hospitalized children was effective for prevention of spread of varicella in a ward. Six to nine months later, there were four separate episodes of varicella and zoster in the same ward. Eighteen children (11 with nephrotic syndrome, 6 with nephritis, and 1 with hepatitis) with no history of varicella were inoculated with a live vaccine before or immediately after admittance or occurence of the varicella and zoster cases. Twelve of them had been receiving steroid therapy and 15 of the 18 were found to be seronegative by complement fixation and neutralization tests before the vaccination. All of them became seropositive after vaccination without any clinical symptoms. The longest period between vaccination and exposure was nine months. None of the vaccinees exhibited varicella symptoms after exposure. Serological follow-up of ten vaccinated children was done, and booster responses were observed in some of them after exposure. These results suggest that the live vaccine affords immunity to the recipients. If hospitalized children are vaccinated before or immediately after exposure, isolation of the patient is unnecessary.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 190584

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  9 in total

Review 1.  25 years' experience with the Biken Oka strain varicella vaccine: a clinical overview.

Authors:  M Takahashi
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 2.  Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults.

Authors:  Kristine Macartney; Anita Heywood; Peter McIntyre
Journal:  Cochrane Database Syst Rev       Date:  2014-06-23

3.  Sensitive solid-phase radioimmunoassay for detection of human immunoglobulin G antibodies to varicella-zoster virus.

Authors:  M G Friedman; S Leventon-Kriss; I Sarov
Journal:  J Clin Microbiol       Date:  1979-01       Impact factor: 5.948

Review 4.  Mumps and varicella vaccines.

Authors:  J A Dudgeon
Journal:  Arch Dis Child       Date:  1980-01       Impact factor: 3.791

5.  Herpes zoster.

Authors:  J B Reuler
Journal:  West J Med       Date:  1978-12

Review 6.  Microbiology laboratory and the management of mother-child varicella-zoster virus infection.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2016-08-12

7.  Nosocomial varicella. Part II: suggested guidelines for management.

Authors:  G F Hayden; J D Meyers; R E Dixon
Journal:  West J Med       Date:  1979-04

8.  Detection of antibodies to varicella zoster virus by radioimmunoassay and enzyme immunoassay techniques.

Authors:  M G Friedman; H Haikin; S Leventon-Kriss; R Joffe; V Goldstein; I Sarov
Journal:  Med Microbiol Immunol       Date:  1978-11-17       Impact factor: 3.402

Review 9.  Viral pneumonias.

Authors:  R C Reichman; R Dolin
Journal:  Med Clin North Am       Date:  1980-05       Impact factor: 5.456

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.